SCIENTIFIC AND CLINICAL REPORT
1. Contributory Effects of Childhood Trauma to White Matter Tract Injury in Human Immunodeficiency Virus (HIV) Infected and Uninfected Women Soraya Seedat, M.D., Ph.D.
2. Mental Health Outcomes for Orphans by AIDS Compared to Orphans by Other Means Carla Sharp, Ph.D.
3. The Outpatient Clinic for HIV and Mental Health: Patients’ Characteristics and Comparison With Homosexual Non-HIV Infected Patients Annemiek Schadé, M.D., Ph.D.
F1. DSM-5: Research and Development Chair: David J. Kupfer, M.D.
L1. Deep Brain Stimulation: Rethinking Depression and Its Treatment APA Frontiers of Science Lecture; Helen S. Mayberg, M.D.
S1. One-Stop Psychiatric Shopping: How to Integrate Medication and Psychotherapy in Your Practice
1. Integrative Strategies in Treating Eating Disorders Joel Yager, M.D.
2. Exploring the Meaning of Medications David L. Mintz, M.D.
3. Combining CBT and Pharmacotherapy in Brief Sessions Jesse H. Wright, M.D., Ph.D.
4. A Private Psychiatric Practice in Rural Vermont: A Return to the Old Frontier Alice Silverman, M.D.
S2. Scope, Current Evidence, and Innovative Approaches in Managing PTSD in the Military
1. Epidemiology and Treatment of PTSD Associated With Combat: A Critical Look at the Evidence Gary H. Wynn, M.D.
2. Psychopharmacologic Treatment for PTSD David M. Benedek, M.D.
3. Understanding the Evidence on Evidence-Based Psychotherapy for PTSD Paula P. Schnurr, Ph.D.
4. Disseminating Effective, Integrated Mental Health and Primary Care Services for PTSD and Depression in the U.S. Military Charles C. Engel, M.D., M.P.H.
5. DoD/APIRE PTSD Care Dissemination Project Farifteh F. Duffy, Ph.D.
S3. Cross-Cultural Issues in the Use of Psychotropic Medications in Children APA Council on Children, Adolescents, and Their Families
1. Perspectives on the Use of Psychotropic Medications in Children in the United States David A. Mrazek, M.D.
2. Perspectives on the Use of Psychotropic Medications in Children in the United Kingdom Sue Bailey, M.D.
3. Perspectives on the Use of Psychotropic Medications in Children in Canada Alice A. Charach, M.D.
4. Perspectives on the Use of Psychotropic Medications in Children in New Zealand P.G. Shelton, M.D.
S4. A Primer on Prevention in Psychiatry
1. An Introduction to Prevention Principles Ruth S. Shim, M.D., M.P.H.
2. Considering Schizophrenia From a Prevention Perspective Michael T. Compton, M.D., M.P.H.
3. Suicide Prevention Frederick J.P. Langheim, M.D., Ph.D.
4. Substance Abuse Prevention Rebecca A. Powers, M.D.
5. A Primer on Prevention in Psychiatry Christopher J. Oleskey, M.D., M.P.H.
S5. Personality Disorders: DSM-5 and Beyond
1. Framing the Debate for DSM-5 Personality Disorders Steven Huprich, Ph.D.
2. Proposed Revisions for DSM-5 Personality Disorders: A Process-Focused Critique and Suggestions for Future Work Groups Robert F. Bornstein, Ph.D.
3. Is There Sufficient Empirical Support for the Proposed Changes for DSM-5 in Diagnosing Personality Disorders? Mark Zimmerman, M.D.
4. Does Neurobiology Support Dimensional Diagnosis of Personality Disorders? Joel Paris, M.D.
5. DSM-5 Personality Disorders and Beyond John Livesley, M.D.
S6. The Long-Term Course of Borderline Personality Disorder: 16-Year Findings From the McLean Study of Adult Development
1. Attainment and Stability of Symptomatic Remission and Recovery Among Patients With BPD and Axis II Comparison Subjects: A 16-Year Follow-Up Study Mary C. Zanarini, Ed.D.
2. Predictors of Suicide Attempts in Patients With BPD Over 16 Years of Prospective Follow-Up Michelle M. Wedig, Ph.D.
3. Utilization of Inpatient and Outpatient Medical Services by Patients With BPD and Axis II Comparison Subjects Over a Decade of Prospective Follow-Up Alex S. Keuroghlian, M.D., M.Sc.
4. Subtypes of Identity Disturbance and Their Impact on the Course of Borderline Personality Disorder Over 16 Years of Prospective Follow-Up Valerie I. Photos, Ph.D.
5. Opioid Use Among Patients With BPD Followed Prospectively for a Decade: Description and Prediction Frances R. Frankenburg, M.D.
S7. Spectrum Disorders: The Syndromal Overlap of Anxiety, Affective Symptoms, and Medical Comorbidity
1. Joint Hypermobility and Anxiety: The Connective Issue Antonio Bulbena, M.D., M.Sc.
2. The ALPIM Syndrome: Anxiety of the Mind and Body, Part I Singh Deepan, M.B.B.S
3. Beyond the Serotonin Hypothesis: Mitochondria and Inflammation in Major Depression and Affective Spectrum Disorders Ann Gardner, M.D., Ph.D.
S8. Integrating the Full Spectrum of Alcohol and Other Drug Problems in Psychiatric and Primary Care
1. Treating Patients With First-Episode Psychosis and Alcohol and Other Drug Use Disorders Robert E. Drake, M.D.
2. The Importance of Integrating Alcohol Treatment Within Mental Health Care Constance M. Weisner, D.P.H., M.S.W.
3. Screening and Treatment of Alcohol Use Among Depression Patients Derek D. Satre, Ph.D.
4. Pharmacotherapy of Alcohol Dependence in Serious and Persistent Mental Illness Steven L. Batki, M.D.
S9. Financing Sustainable Interdisciplinary Care in Psychiatric and General Medical Settings
1. Clinical and Systems-Level Models for Improving Care on the Primary Care/Mental Health Interface Benjamin G. Druss, M.D., M.P.H.
2. The High Cost of Comorbid Chronic Medical and Behavioral Conditions: An Opportunity for Creative Payment Reform for Integrated Medical-Behavioral Care Stephen P. Melek
3. Carved In, Carved Out, and Cut Up: The Status Quo of Current Funding Schemes for Integrated Psychiatric Treatment and Primary Care Anita S. Everett, M.D.
4. Integrated Claims Adjudication as a Strategy for Reversing the Negative Effects of Comorbid General Medical and Psychiatric Disorders Roger Kathol, M.D.
W1. Update on Parasomnias: A Review for Psychiatric Practice Chairs: Dimitri D. Markov, M.D., Marina Goldman, M.D.
W2. Management Strategies for Antisocial Personality Disorders Chair: Donald W. Black, M.D.
W3. Reefer Madness? The Role of Psychiatry in the Evolution of Marijuana as a Medical Treatment Chair: Christopher A. Milburn, M.D., M.S.
W4. Prevention of Mental Health Sequelae: Evidence-Based Practices in Protection, Prevention, and Intervention in African-American Population APA Caucus of Black Psychiatrists; Chairs: Napoleon B. Higgins, M.D.
W5. Workshop on Integration of Primary Care, Preventive Services, and Assertive Community Treatment Team Chairs: Erik R. Vanderlip, M.D., Nancy A. Williams, M.D.
W6. A Historical Overview of the Inception of Moral Treatment in Psychiatry Chair: David S. Roby, M.D.
W7. Training for the Future: Addressing Community Psychiatry Workforce Shortages and Health Care Reform Through Resident Training in Public Psychiatry Chairs: Matthew D. Erlich, M.D., Sharat G. Parameswaran, M.D.
F2. Alcohol Screening and Brief Intervention for Youth:The NIAAA Practitioner’s Guide Chair: Vivian B. Faden, Ph.D.
L2. Judd Marmor Award Lecture Robert E. Hales, M.D.
SCIENTIFIC AND CLINICAL REPORT
SCR2. Attention Spectrum Disorders 2
1. Prevalence of ADHD and Comorbid Psychiatric Disorders in a Veterans Administration Outpatient Clinic Robert Kayser, M.D.
2. Adult Attention-Deficit/Hyperactivity Disorder and Anxiety Disorders: Prevalence in a Clinical Sample Michael Van Ameringen, M.D.
3. Duration of Action of Lisdexamfetamine Dimesylate in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder David Coghill, M.D.
W8. Helping Patients Who Drink Too Much: Using the NIAAA Clinician’s Guide U.S. National Institute on Alcohol Abuse and Alcoholism; Chair: Mark L. Willenbring, M.D.
W9. The Ethics of Patient-Targeted Googling Chair: David H. Brendel, M.D., Ph.D.
W10. Health Care Reform and Psychiatry Training for Primary Care Physicians: What to Teach, How to Teach, Where to Teach Chairs: Hoyle Leigh, M.D., Jon Streltzer, M.D.
W11. Electronic Health Records (EHRs): What to Look for When Selecting an EHR for Your Practice APA Committee on Electronic Health Records; Chairs: Steven R. Daviss, M.D., Robert M. Plovnick, M.D., M.S.
W12. Addressing Addiction Among Women: A U.S.A. Perspective Chair: Pedro Ruiz, M.D.
W13. Evidence-Based Integrative Treatments for Anxiety, Depression, and Trauma in Mass Disasters APA Caucus on Alternative and Complementary Medicine; Chairs: Helen Lavretsky, M.D., M.S., Patricia L. Gerbarg, M.D.
L3. Understanding Patients With Borderline Personality Disorder APA International Psychiatrist Lecture; Sabine C. Herpertz, M.D.
L4. Dialectical Behavior Therapy: Where It Started, Where It Went, Where It May Be Now, and Where Are We Going? APA Frontiers of Science Lecture; Marsha M. Linehan, Ph.D.
L5. Teaching Illness Self-Management to Improve the Integration of Care Among Hispanics Simon Bolivar Award Lecture; Alex J. Kopelowicz, M.D.
W14. Psychiatrists’ Response to Young Adult Patients Who Have Had Inappropriate or Abusive Care in Residential Treatment as Adolescents Chair: Charles W. Huffine, M.D.
W15. Computer-Assisted Cognitive-Behavior Therapy for Depression Chairs: Jesse H. Wright, M.D., Ph.D., Michael E. Thase, M.D.
W16. 2012 Revision of the Schizophrenia Psychopharmacology Algorithm From the Harvard South Shore Psychiatry Program Chair: David N. Osser, M.D.
W17. Promoting Emotional and Physical Safety During Residency: Being Prepared for Life-Threatening Emergencies Chairs: Curtis A. McKnight, M.D., David P. Kasick, M.D.
W18. Clinical Wisdom in Psychotherapy: A Philosophical and Qualitative Report APA/The Scattergood Foundation; Chair: Dominic Sisti, Ph.D.
W19. Don’t You Want to Be a Real Doctor? Overcoming Career Development Challenges Faced by Asian Americans in Psychiatry APA Caucus of Asian-American Psychiatrists; Chairs: Sharat G. Parameswaran, M.D., Russell F. Lim, M.D.
SCIENTIFIC AND CLINICAL REPORTS
SCR3. Biological Studies of Brain Functioning
1. Brain-Derived Neurotrophic Factor Moderates Effects of Job Stress on the Severity of Alcohol Drinking in Korean 20s Office Workers BoAh Kim, M.D.
2. Significant Association Between IQ and Degree of Overall Cortical Gyrification Venkataramana Bhat, M.D.
SCR4. Bipolar Disorders, Part 1
1. The Clinical Demographics of the Mayo Clinic Bipolar Disorder Biobank Manuel Fuentes, M.D.
2. Diagnostic Stability of DSM-IV Clinical Diagnosis of Bipolar Disorder Bonnie Szarek, R.N.
3. Should the Diagnostic Criteria for Bipolar Disorder be Broadened? Implications From Longitudinal Studies of Sub-threshold Conditions Mark Zimmerman, M.D.
4. Misuse of the Mood Disorders Questionnaire as a Case-Finding Measure and a Critique of the Concept of Using a Screening Scale for Bipolar Disorder Mark Zimmerman, M.D.
PS1. Teaching Psychodynamic Psychiatry in the 21st Century Chairs: John Oldham, M.D., Carol Nadelson, M.D.
1. Teaching Psychotherapy Deborah Cabaniss, M.D.
2. Everyone Is a Psychoanalyst Richard F. Summers, M.D.
3. Making It So: Creating a Psychodynamic Research Clinic Kimberlyn Leary, Ph.D., M.P.A.
PS2. Mindfulness-Based Practices in the Treatment of Stress and Psychiatric Illness Chair: Kathy M. Sanders, M.D.
1. Mindfulness-Based Stress Reduction (MBSR): What It Is and Its Clinical Applications for Stress, Pain, and Chronic Illness Jon Kabat-Zinn, Ph.D.
2. Mindfulness-Based Cognitive Therapy (MBCT) in the Treatment and Prevention of Relapse in Major Recurrent Depression Peter Beiling, Ph.D.
3. Probing the Molecular Mechanism of Mind-Body Practices With Genomic and Translational Techniques John W. Denninger, M.D., Ph.D.
4. Changes in Neural Structure and Function Associated With Mindfulness Training Programs Sara Lazar, Ph.D.
S10. Social Stress and Drug Addiction in Preclinical and Clinical Studies: Sex/Gender Matters in Effects on Brain and Behavior and Treatment Implications
1. Monkey Models of Social Stress and Cocaine Abuse: Sex Differences Michael A. Nader, Ph.D.
2. Social Stress Differentially Affects Drug Reward in Adolescent Male and Female Rats Sari Izenwasser, Ph.D.
3. From Picture to Practice: The Role of Gender and Affect on the Neural Response to Social Stress in Cocaine Users Colleen A. Hanlon, Ph.D.
4. Sex Difference in Reactivity to Laboratory-Induced Stress and Drug Cues Sudie Back, Ph.D.
S11. Field Trial Testing of Proposed Revisions to DSM-5: Findings and Implications American Psychiatric Institute for Research and Education
1. DSM-5 Field Trials: New Methods, New Insights Helena C. Kraemer, Ph.D.
2. DSM-5 Field Trials in Academic or Large Clinical Settings: Detailed Findings for Schizophrenia, Depression, and ADHD Darrel A. Regier, M.D., M.P.H.
3. DSM-5 Field Trials in Academic or Large Clinical Settings: Summary and Implications Diana E. Clarke, Ph.D., M.Sc.
4. Dimensional Measures in Psychiatric Diagnosis: Results From the DSM-5 Field Trials William E. Narrow, M.D., M.P.H.
5. Testing DSM-5 in Routine Clinical Practice Settings: Trials, Tribulations, and Triumphs Eve K. Moscicki, Sc.D., M.P.H.
S12. Rebound and Recovery in the Athlete International Society for Sport Psychiatry
1. Doping in Sports: What‘s on the Horizon? David A. Baron, D.O.
2. Sexual Harassment and Abuse in Sports: What It Is, How to Prevent It. Discussion With Former NHL Player Sheldon Kennedy Saul I. Marks, M.D.
3. Psychological Impact of Injury on the Athlete Thomas S. Newmark, M.D.
4. Doping in Elite Cycling: A Psychiatric Perspective on Causes, Consequences, Recovery, and Rehabilitation Alan Currie, M.B.B.S.
S13. Time-Limited Psychotherapy for Cancer: From Diagnosis to Remission or End of Life
1. Assessment and Treatment of Cancer Patients for Time-Limited Psychotherapy: Who’s Appropriate at What Stage? Anton C. Trinidad, M.D.
2. Palliative Psychotherapy—When the Prognosis Seems Bleak Lorenzo Norris, M.D.
3. Case Presentation I Amanda Crosier, M.D.
4. Case Presentation II Sanaz Kumar, M.D.
S14. When Your Patient Is a Parent: Supporting the Family and Addressing the Needs of Children
1. Overview of Needs of the Children of Parents With Mental Illness Alison M. Heru, M.D.
2. Clinical Implications of Evidence-Based Preventive Interventions for Families With Parental Depression William R. Beardslee, M.D.
3. A Family Perspective from Julie Totten, President and Founder of Families for Depression Awareness Julie Totten, M.B.A.
S15. Pros and Cons of SPECT Brain Imaging: What Is the Status of the Science?
1. Capturing Mental Illness in a Brain Scan: Dream or Reality? Anissa Abi-Dargham, M.D.
2. SPECT Imaging in Psychiatric Practice: Ready for Prime Time? Jair C. Soares, M.D.
3. Brain SPECT Imaging Is Immediately Useful in Clinical Practice Daniel G. Amen, M.D.
4. Bringing SPECT Functional Neuroimaging Into Perspective Theodore A. Henderson, M.D., Ph.D.
S16. Forensic Psychiatry: Informing Clinical Practice
1. Looking Beyond Patients’ Denial of Suicidal Ideation: Assessing Observable Evidence-Based Risk Factors Robert I. Simon, M.D.
2. Disability Evaluations: A Model for Assessment Liza H. Gold, M.D.
3. Neuroimaging in Forensic Psychiatry: Current Status and Future Directions Robert P. Granacher, M.D., M.B.A.
4. Correctional Psychiatry Joseph Penn, M.D.
5. The Internet and Psychiatry: An Update on Legal and Ethical Considerations Patricia R. Recupero, M.D., J.D.
6. Child Forensic Psychiatry: 21st Century Practice Cheryl D. Wills, M.D.
S17. STEPPS (Systems Training for Emotional Predictability and Problem Solving): Treating Borderline Personality Disorder in Diverse Settings Around the Globe
1. Overview of STEPPS Treatment Program and Its Implementation in Correctional Settings (Prisons and Community Corrections) Nancee S. Blum, M.S.W., L.C.S.W.
2. Implementing STEPPS in Different Service Settings in the United Kingdom Renee Harvey, M.A.
3. STEPPS in the Netherlands: The Efficacy in a Group of Dutch Patients With Borderline Personality Disorder and With Borderline Personality Features E. van Wel, M.D.
4. STEPPS Treatment of Inpatients With Mood Disorders and Co-occurring Borderline Personality Disorder Diagnosis: Preliminary Results From a One-Year Follow-Up Study Andrea Fossati, M.D., Ph.D.
S18. Narcissistic Personality Disorder in DSM-5: Impact on Research, Diagnosis, and Treatment
1. Narcissistic Personality Disorder in DSM-5 Andrew E. Skodol, M.D.
2. Finding Common Denominators: Understanding the Association of Depression, Depressive Personality, and Hypersensitive (Vulnerable) Narcissism Steven Huprich, Ph.D.
3. Narcissistic Grandiosity and Narcissistic Vulnerability: Clinical Examples, Current Research, and Implications for DSM-5 Aaron L. Pincus, Ph.D.
4. Narcissistic Personality Disorder: An Interactive Exploratory Diagnostic Process Elsa Ronningstam, Ph.D.
5. Transference-Focused Psychotherapy for Narcissistic Personality Disorder Diana Diamond, Ph.D.
S19. Philosophical and Pragmatic Problems for DSM-5
1. The Ideology Behind DSM-5 Joel Paris, M.D.
2. The Conceptual Status of DSM Diagnoses James E. Phillips, M.D.
3. Considering the Economy of DSM Alternatives John Z. Sadler, M.D.
4. What Are the Benefits and Risks of Conservatism? G. Scott Waterman, M.D.
5. The Pragmatic Context of Psychiatric Diagnosis Joseph M. Pierre, M.D.
S20. New Paradigms for Investigating Relational Disturbances in Borderline Personality Disorder
1. Attachment and Cognition in BPD: Problems in Integrating Complex Information in Emotionally Stimulated Attachment Contexts Lois W. Choi-Kain, M.D., M.Ed.
2. Rejection Sensitivity as a Distinguishing Feature of Borderline Personality Disorder Valerie I. Photos, Ph.D.
3. Empathy, Attachment, and Borderline Personality: Genetic, Neurobiological, and Developmental Perspectives Luis H. Ripoll, M.D.
4. Emerging Investigational Paradigms for the Empirical Study of Rejection Sensitivity Alex S. Keuroghlian, M.D., M.Sc.
5. Neuroimaging of Social Exclusion in Borderline Personality Disorder Anthony C. Ruocco, Ph.D.
L6. Schizophrenia as a Learning and Memory Disorder APA Distinguished Psychiatrist Lecture; Carol A. Tamminga, M.D.
L7. Musings on Decades of Progress in Alcoholism Treatment Research U.S. National Institute on Alcohol Abuse and Alcoholism; Bankole A. Johnson, M.D.
SCIENTIFIC AND CLINICAL REPORTS
SCR5. Bipolar Disorders, Part 2
1. Is Antidepressant Use in Bipolar Disorder Associated With Higher Readmission Rates? Megan Ehret, Pharm.D.
3. Increased Life Events in Bipolar II Patients Participating in Bipolar Biobank Mohit Chauhan, M.B.B.S.
SCR6. Borderline Personality Disorder, Diagnostic Issues
1. Is Dimensional Scoring of Borderline Personality Disorder Only Important for Subthreshold Levels of Severity? Mark Zimmerman, M.D.
2. Distinguising Bipolar II and Borderline Personality Disorder: A Review of Current Literature Katy Crow
3. Borderline Personality Disorder and Atypical Depression: Controversies and Convergences Ana Marie Rodriguez-Villa
W20. Understanding Genetics: It’s Not Just Mendelian Anymore Chair: Michele T. Pato, M.D.
W21. Children of Psychiatrists Chairs: Michelle B. Riba, M.D., M.S., Leah J. Dickstein, M.D., M.A.
W22. Promoting Improved Integration: The Role of Collaborative Health Care in Today’s Society Chair: Peter S. Martin, M.D., M.P.H.
W23. Responding to the Impact of Suicide on Clinicians Chair: Eric M. Plakun, M.D.
W24. Making the Most of Your Chief Year: Chief Residents’ Forum 1 Chairs: Margaret E. Haglund, M.D., Jason E. Cheng, M.D.
W25. Joining the Ranks of Military Psychiatry as a Civilian Contractor: Lessons Learned Chair: Elspeth C. Ritchie, M.D., M.P.H.